P. Kertes

Ophthalmology · 2006

A researcher in the Science corpus: 1 paper; trusts 1 researcher and is trusted by 2 researchers here, as inferred from the citation graph.

Subfields

Whom P. Kertes trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

  1. R. Spaide

Who trusts P. Kertes overall

  1. David M. Brown
  2. Ursula Schmidt-Erfurth

Papers from P. Kertes's perspective

Ordered by how strongly the researchers P. Kertes trusts endorse each paper. Same corpus, a different order for every researcher.

  1. Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer. (New England Journal of Medicine)
  2. INTRAVITREAL BEVACIZUMAB TREATMENT OF CHOROIDAL NEOVASCULARIZATION SECONDARY TO AGE-RELATED MACULAR DEGENERATION (Retina)
  3. Intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration. (Ophthalmology (Rochester, Minn.))
  4. Pegaptanib for neovascular age-related macular degeneration. (New England Journal of Medicine)
  5. Benefits of targeting both pericytes and endothelial cells in the tumor vasculature with kinase inhibitors. (Journal of Clinical Investigation)
  6. Paclitaxel plus bevacizumab versus paclitaxel alone for metastatic breast cancer. (New England Journal of Medicine)
  7. Adaptive recognition by nucleic acid aptamers. (Science)
  8. Quantitative optical coherence tomography angiography of choroidal neovascularization in age-related macular degeneration (Ophthalmology (Rochester, Minn.))
  9. Proposed lexicon for anatomic landmarks in normal posterior segment spectral-domain optical coherence tomography: the IN•OCT consensus. (Ophthalmology (Rochester, Minn.))
  10. VEGF-Trap: A VEGF blocker with potent antitumor effects (Proceedings of the National Academy of Sciences of the United States of America)

Their papers